Portal de investigación
Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Terol, I.
- Argumanez, V.
- Cerrillo, E.
- Garrido, A.
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Minguez,A,Bastida,G,Terol,I,Argumanez,V,Iborra,M,Aguas,M,Moret,I et al. Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:OXFORD UNIV PRESS. 2023 p.p. 781-782.